Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Schizophrenia
Recent news which mentions Schizophrenia
Taye Diggs: My sister's schizophrenia diagnosis changed our family—and how I handle my own anxiety: I 'follow her lead'
May 28, 2025
Tags
Mental health
Make It / Life
Health Tips and Wellness Advice
From
CNBC.com News
Thanksgiving Small Bits & Pieces
December 02, 2024
Tags
schizophrenia
Doc Gumshoe
coronavirus
From
Stock Gumshoe
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
November 11, 2024
Tickers
ABBV
BMY
NEWS
Tags
BMY
Briefs
Market News
From
Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
October 07, 2024
Tickers
BMY
NEWS
RVPH
Tags
Biotech
Stories That Matter
Expert Ideas
From
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
August 30, 2024
Tickers
BMY
EIX
LUCY
O
Tags
dividens
LUCY
Benzinga
From
Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
Tags
Guidance
Psychedelic/Assisted Therapies
Market News
From
Benzinga
Psychedelics And Schizophrenia: What's The Link?
February 19, 2023
Tags
LSD
Benzinga
contributors
From
Benzinga
Tips on Managing Your Schizophrenia
August 22, 2022
Tickers
ALKS
Tags
Schizophrenia
Health & Healthcare
NASDAQ:ALKS
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise
June 08, 2022
Tickers
CBD
CURLF
Tags
Leafreport
marijuana
CBD
From
Benzinga
Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
April 06, 2022
Tickers
ADXN
Tags
Benzinga
Schizophrenia
General
From
Benzinga
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial
February 24, 2022
Tickers
KRTX
Tags
Movers
Market News
News
From
Benzinga
Cannabis Increases Odds Of This Disorder In Teens Despite Infrequent Use
February 08, 2022
Tags
mental health
Markets
Cannabis
From
Benzinga
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
February 08, 2022
Tickers
ALKS
Tags
Benzinga
Schizophrenia
ALKS
From
Benzinga
Alkermes Highlights Signs and Symptoms of Schizophrenia
January 31, 2022
Tags
Schizophrenia
mental health
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial
January 10, 2022
Tickers
RVPH
Tags
Briefs
Movers
Market News
From
Benzinga
FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders
December 01, 2021
Tickers
BTAI
Tags
Health Care
News
Trading Ideas
From
Benzinga
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
November 22, 2021
Tickers
NBIX
Tags
News
Health Care
NBIX
From
Benzinga
ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study
November 01, 2021
Tickers
ATAI
Tags
Health Care
Trading Ideas
News
From
Benzinga
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
November 01, 2021
Tickers
TEVA
Tags
Benzinga
Schizophrenia
General
From
Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
September 30, 2021
Tickers
NERV
Tags
Trading Ideas
News
Penny Stocks
From
Benzinga
Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program
September 13, 2021
Tickers
ALKS
Tags
Philanthropy & Cause Initiatives
opioid use disorder (OUD)
bipolar disorder
From
3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Approves First And Only Twice-Yearly Schizophrenia Drug
September 01, 2021
Tickers
JNJ
Tags
Market News
Biotech
FDA
From
Benzinga
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
September 01, 2021
Tickers
TEVA
Tags
News
Schizophrenia
General
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.